Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Official title: The Embryo Health Study: Prospective Longitudinal Analysis of PGT-P
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2020-12-01
Completion Date
2025-12-01
Last Updated
2025-08-26
Healthy Volunteers
Yes
Conditions
Interventions
Preimplantation Genetic Testing
Embryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.
Locations (1)
Genomic Prediction Clinical Laboratory
North Brunswick, New Jersey, United States